Massachusetts Financial Services
JAZZ icon

Massachusetts Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Massachusetts Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
6,386
+216
+4% +$47.3K ﹤0.01% 850
2026
Q1 		$1.17M Sell
6,170
-2,395
-28% -$419K ﹤0.01% 837
2025
Q4 		$1.46M Sell
8,565
-284
-3% -$43.5K ﹤0.01% 811
2025
Q3 		$1.17M Buy
8,849
+582
+7% +$69.8K ﹤0.01% 796
2025
Q2 		$877K Buy
+8,267
New +$898K ﹤0.01% 823
2014
Q2 		– Sell
-96,630
Closed -$13.4M – 902
2014
Q1 		$13.4M Buy
+96,630
New +$14.5M 0.01% 558

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Massachusetts Financial Services's JAZZ Position: Q2 2026 in Review

Massachusetts Financial Services increased its Jazz Pharmaceuticals (JAZZ) stake by 3.5% in Q2 2026, buying an estimated $47.3K and bringing the position to 6,386 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #850.

Massachusetts Financial Services first reported a position in JAZZ in Q1 2014 and has held it in 6 quarters since. The position peaked at $13.4M in Q1 2014. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Massachusetts Financial Services held 6,386 shares of Jazz Pharmaceuticals worth $1.54M as of Q2 2026.
  • Massachusetts Financial Services bought 216 Jazz Pharmaceuticals shares in Q2 2026, an estimated $47.3K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #850 holding.
  • Massachusetts Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 6 quarters since.
  • Massachusetts Financial Services's Jazz Pharmaceuticals position peaked at $13.4M in Q1 2014.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.